Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Prices $500M Senior Notes Offering

NEW YORK – Agilent Technologies announced today that it has priced an underwritten, registered public offering of a series of its senior notes, in an aggregate principal amount of $500 million.

In a filing with the US Securities and Exchange Commission, the company said that the notes will mature in September 2029 and will bear interest at an annual rate of 2.750 percent. The offering is expected to close on Sep. 16, and Agilent is expecting net proceeds of approximately $492.8 million.

The company plans to use the funds from the offering, as well as cash on hand, to redeem its outstanding 5.00 percent senior notes due 2020.

Barclays Capital, JP Morgan Securities, and MUFG Securities Americas are acting as joint book-running managers.

Agilent's shares were up a fraction of 1 percent to $73.90 in Friday morning trading on the New York Stock Exchange.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.